$VBLT between the line there is breaking news from this conference - it looks to me VB-111 already showed statistical significance results in progression free survival but not yet at overall survival. There were hints before this conference that this is the case but now the comments from ceo and Dr Monk saying we better change the endpoint before the trial end implies that.